The steady-state pharmacokinetics and bioavailability of buprenorphine following multiple administration (10 daily doses) of two 8mg buprenorphine sublingual tablets (Reckitt & Colman) will be compared to those of 1mL of 8mg/mL sublingual solution (buprenorphine hydrochloride in 30% ethanol) in opiate dependent subjects. In addition, the subjective and physiological effects of buphrenorphine produced by multiple administration of the two dosage forms at steady state will also be compared.
Showing the most recent 10 out of 1085 publications